Cryofocus Medtech (Shanghai) Co., Ltd. (HKG:6922)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.50
+0.05 (0.92%)
At close: Mar 27, 2026

HKG:6922 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
95.2753.5340.9527.1522.43
Revenue Growth (YoY)
77.97%30.72%50.83%21.06%147.69%
Cost of Revenue
31.2815.129.97.796.88
Gross Profit
63.9838.4131.0519.3615.55
Selling, General & Admin
76.9895.2874.788.3355.56
Research & Development
30.4473.4676.1359.9338.85
Operating Expenses
107.41168.74150.82148.2694.41
Operating Income
-43.43-130.33-119.77-128.9-78.87
Interest Expense
-1.95-1.09-0.65-0.59-0.38
Interest & Investment Income
-0.231.221.192.98
Currency Exchange Gain (Loss)
-1.161.72.62-
Other Non Operating Income (Expenses)
0.9318.8911.757.360.74
EBT Excluding Unusual Items
-44.46-111.14-105.75-118.32-75.52
Other Unusual Items
-----50.97
Pretax Income
-44.46-111.14-105.75-118.32-126.5
Income Tax Expense
-0.13---
Earnings From Continuing Operations
-44.46-111.28-105.75-118.32-126.5
Minority Interest in Earnings
6.296.918.266.0924.62
Net Income
-38.17-104.37-97.49-112.22-101.87
Net Income to Common
-38.17-104.37-97.49-112.22-101.87
Shares Outstanding (Basic)
239239239228228
Shares Outstanding (Diluted)
239239239228228
Shares Change (YoY)
-0.23%-4.86%0.01%-
EPS (Basic)
-0.16-0.44-0.41-0.49-0.45
EPS (Diluted)
-0.16-0.44-0.41-0.49-0.45
Free Cash Flow
--84.79-111-103.95-74.93
Free Cash Flow Per Share
--0.35-0.46-0.46-0.33
Gross Margin
67.16%71.75%75.83%71.32%69.32%
Operating Margin
-45.59%-243.46%-292.48%-474.77%-351.68%
Profit Margin
-40.06%-194.96%-238.06%-413.36%-454.26%
Free Cash Flow Margin
--158.39%-271.05%-382.87%-334.11%
EBITDA
-37.17-124.06-114.35-124.34-76.14
EBITDA Margin
-39.01%-231.76%-279.25%--
D&A For EBITDA
6.266.265.424.552.73
EBIT
-43.43-130.33-119.77-128.9-78.87
EBIT Margin
-45.59%-243.46%-292.48%--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.